With near 39,000 new cases, India’s COVID-19 tally crosses 1.07m

A doctor wearing a protective face shield uses an infrared thermometer to measure the temperature of a child at his mobile health clinic, after his clinic and its adjoining areas were declared a micro-containment zone, after authorities eased lockdown restrictions that were imposed to slow the spread of the coronavirus disease (COVID-19), in Ahmedabad, India on 15 June.
A doctor wearing a protective face shield uses an infrared thermometer to measure the temperature of a child at his mobile health clinic, after his clinic and its adjoining areas were declared a micro-containment zone, after authorities eased lockdown restrictions that were imposed to slow the spread of the coronavirus disease (COVID-19), in Ahmedabad, India on 15 June.Reuters

Close to 39,000 new cases were reported in past 24 hours taking India’s total coronavirus cases to 1,077,618. With 543 deaths the toll stood at 26,816, Health Ministry data said.

Karnataka is the new hotspot state nearing 60,000 cases, as Maharashtra remained the worst-hit state, with 300,937 cases and 11,596 casualties. It crossed the 300,000 mark on Saturday with Mumbai reporting over 100,000 coronavirus cases so far. It is followed by Tamil Nadu with total 165,714 cases, including 2,403 deaths.

Advertisement

The national capital, on the other hand is projecting an uplifting trend. For 17 of the last 20 days, including 11 in a row now, the number of people recovering from COVID-19 in Delhi has remained higher than newly detected infections—no other state has come close to such a trend.

According to Health Ministry data, as many as 677,422 patients have recovered, almost twice the number of active patients at 3,73,379, though India continues to be the third worst-affected country after the US and Brazil.

Advertisement

In the last 24 hours, 358,127 samples were tested, as the testing lab network continued to expand.

States with more than 10,000 cases include Karnataka (59,652), Gujarat (47,390), Uttar Pradesh (47,036), Rajasthan (28,500), Madhya Pradesh (21,763), West Bengal (40,209), Haryana (25,547), Andhra Pradesh (44,609), Telangana (43,780), Assam (22,918), Jammu and Kashmir (13,198), Kerala (11,659), Odisha (16,701) and Bihar (25,136).

Advertisement

The AIIMS Ethics Committee has given its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday.

Globally, over 14 million people have been infected with the virus and 602,656 have died. It has taken just four days to climb to 14 million cases from 13 million recorded on 13 July.